38990-17-9 Usage
Uses
Used in Pharmaceutical Industry:
Methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate is used as a pharmaceutical agent for its potential therapeutic effects. methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate's unique structure allows it to interact with specific biological targets, making it a promising candidate for the development of new drugs to treat various diseases.
Used in Research and Development:
methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate is also used in research and development for its potential applications in the field of medicinal chemistry. Scientists and researchers can study its interactions with different biological systems to gain insights into its mechanism of action and explore its potential as a lead compound for drug discovery.
Used in Drug Delivery Systems:
Similar to gallotannin, novel drug delivery systems can be developed to enhance the applications and efficacy of methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate. By employing various organic and metallic nanoparticles as carriers, the compound's delivery, bioavailability, and therapeutic outcomes can be improved.
Used in Nootropic Applications:
As a diastereomer of a known nootropic agent, methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate may also be used to combat the effects of aging or in conjunction with other nootropics for a variety of purposes. Its potential as a peripheral vasodilator that increases blood flow to the brain could make it a valuable addition to the nootropic market.
Check Digit Verification of cas no
The CAS Registry Mumber 38990-17-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,9,9 and 0 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 38990-17:
(7*3)+(6*8)+(5*9)+(4*9)+(3*0)+(2*1)+(1*7)=159
159 % 10 = 9
So 38990-17-9 is a valid CAS Registry Number.
38990-17-9Relevant academic research and scientific papers
Synthesis of 18-hydroxyvincamines and epoxy-1,14-secovincamines; A new proof for the aspidospermane-eburnane rearrangement
Nemes, Andras,Szantay Jr., Csaba,Czibula, Laszlo,Greiner, Istvan
, p. 2347 - 2362 (2008/09/18)
Chemical transformations started from tabersonine were studied. A one-pot oxidative ring-transformation with permaleic acid in methanol yielded 17,18-dehydrovincamine. Hydroboration-oxidation of the latter compound led to alkaloid 17,18-dehydrovincamone. Hydroboration-oxidation of tabersonine resulted 14β-hydroxyvincadifformine and 15β-hydroxyvincadifformine. Allowing 14β- and 15β- hydroxyvincadifformines to react with permaleic acid/methanol provided 1,14-secovincamines, serving as new evidence for the mechanism of the aspidospermane-eburnane transformation. On the other hand 18β-hydroxyvincamine was obtained from 14β-hydroxyvincadifformine by reaction with 3-chloroperbenzoic acid and successive treatment with triphenylphosphine/aqueous acetic acid.
